Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, indicating a new published revision of the record. This appears to be a small, internal version update with no visible changes to the study details or data.
    Difference
    0.0%
    Check dated 2026-07-04T04:17:48.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer software patch for the study record; there are no described content changes in this update.
    Difference
    0.0%
    Check dated 2026-06-27T02:48:41.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment section was updated; the heading was normalized from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag updated to v3.6.0 from v3.5.5. A note states that no participants are being recruited anymore, indicating enrollment is closed.
    Difference
    0.3%
    Check dated 2026-06-12T17:32:40.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.5.5) replacing the previous v3.5.4. This indicates a minor update to the page.
    Difference
    0.0%
    Check dated 2026-06-05T17:29:02.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page’s revision label was updated to v3.5.4, replacing the previous v3.5.3, indicating an incremental update to the page’s versioning. This is an internal metadata change and does not modify the study content or how information is presented to users.
    Difference
    0.0%
    Check dated 2026-05-15T05:50:09.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page’s interface revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a release change to the site software rather than any modification to the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T05:54:21.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.